The present study explores the interactions between lymphocytes and monocytes that are required for expression of 
Introduction
Cell-mediated immunity is typified by the delayed type hypersensitivity (DTH)' reaction. A hallmark of the lesion is the deposition of fibrin which accounts for the characteristic induration distinguishing positive from negative reactions (1, 2) . It seems unlikely that nonspecific tissue damage is the initiator of this coagulation. In the model of experimental allergic encephalomyelitis, one of the earliest identifiable abnormalities is fibrin
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Received for publication 26 February 1985 and deposition (3) . This argues for coagulation occurring relatively early in the course of immune lymphocyte activation. Such lymphocyte activation in response to protein antigen requires antigen presentation by monocyte/macrophages (4) or dendritic cells (5) , although other cells (6, 7) can also perform this function.
Antigen presenting cells share the feature of expressing Ia-like antigens on their surface (6) (7) (8) . The Ia protein provides the context for T cells to recognize foreign antigens, and it is here that the specificity of the immune response may be controlled (8) .
A likely mediator of coagulation in immune-mediated reactions is the procoagulant activity (PCA) that can be induced to appear on the surface of cells of the monocyte/macrophage lineage (9) . Peripheral blood mononuclear cells (PBM) can be induced to produce large amounts of PCA in response to mitogenic lectins (10) , bacterial lipopolysaccharide (LPS) (I 1), antigen/antibody complexes (12) , proteolytic products of complement activation (13) , sensitizing protein antigens (14) , and allogeneic stimuli (15) . The PCA is expressed and contained by monocytes, not lymphocytes (16) (17) (18) , and is cell bound, not released into the medium (18, 19) . To date, cellular interactions between lymphocytes and monocytes that culminate in monocyte PCA production have been described in systems with polyclonal stimuli that do not require specific recognition (16) (17) (18) . Neither LPS or antigen/antibody complexes have been shown to have a role in DTH; and the time course of monocyte PCA production in response to these stimuli (6 h ) is not at all in line with the time course of DTH reactions (24-48 h) . The present studies, therefore, addressed the cellular events required for expression ofmonocyte PCA in response to a sensitizing protein antigen. The cellular pathways were found to differ markedly from those previously described in LPS or immune complex induced PCA. In addition, the time course of the process correlated nicely with the appearance of fibrin in in vivo cell-mediated immune tissue lesions.
Methods
Cell isolation and culture. Mononuclear cells were isolated from the peripheral blood of fasting healthy donors by centrifugation over FicollHypaque at 1,400 g, 22'C, for 12 min, as previously described (18) . The PBM contained an average of 78% lymphocytes, 22% monocytes, and <1% polymorphonuclear leukocytes as assessed by Wright's stain and nonspecific esterase stains (20) . Platelet contamination of PBM could be reduced to <0.01 platelets/mononuclear cell by centrifuging whole blood at 120 g for 15 min, removing the platelet-rich plasma before Ficoll-Hypaque centrifugation, and subsequent centrifugation ofthe isolated PBM at 120 g for 5 min through a l-ml cushion of fetal calf serum (FCS) (Sterile Systems, Logan, UT). The mononuclear cells were washed twice in RPMI-1640 (Gibco Laboratories, Grand Island, NY) containing 100 U/ml penicillin, 50 ug/ml streptomycin, 2 mM Hepes (Gibco Laboratories), pH 7.4, and resuspended in the above medium containing 10% heat-activated FCS. All media were prepared with pyrogen-free water and stored in acid washed, high temperature baked glassware. Monocytes RPMI/l0% FCS in 16-mm wells of plastic tissue culture plates (Costar 24, Cambridge, MA). 1 ml of cells was added to each well at 370C and 5% CO2 for 24-48 h. Nonadherent cells (lymphocytes) were removed by vigorously washing with RPMI-1640, and the adherent cells (monocytes) were detached by incubating wells at 4VC for 45 min in Puck's saline A containing 3 mM EDTA and 3% (wt/vol) bovine serum albumin. Lymphocyte recovery was 67±7% and monocyte recovery was 66±8%. All monocyte populations were >98% nonspecific esterase positive, with no identifiable platelets by light microscopy. Lymphocyte fractions contained <2% cells staining positive for nonspecific esterase. PBM at I X 106/ml, isolated lymphocytes at 8 X 105/ml, or isolated monocytes at 2 X 105/ml were incubated in 12 X 75-mm polypropylene tubes (Falcon Labware, Oxnard, CA) in RPMI/l0% FCS with indicated stimuli at 37OC, 5% CO2. After incubation for the times indicated in the text, the cells were washed twice with RPMI-1640 and resuspended in 0. 
Results
To establish immunologic specificity of the PCA response to soluble protein antigens, PBM from eight individuals skin test positive to PPD (>10 mm induration in response to 5 U PPD) but without exposure to tularemia, and three individuals sensitized to tularemia (immunized with single intradermal injection of Francisella tularensis LVS, reference 23) but not skin test positive to PPD, were incubated with each antigen for 48 h and the level of PCA expressed on the surface of viable cells determined. Table I demonstrates a 5-6-fold increase in PCA of PBM exposed to sensitizing antigen compared with cells exposed to nonsensitizing, or to no antigen. Comparison of PCA to the proliferative response was used to confirm antigen specificity (Table I) . PBM incorporated high levels of [3H]thymidine only upon exposure to relevant antigen.
Time course ofPCA expression. To determine the kinetics of the PCA response, PBM were cultured in the presence or absence ofthe appropriate sensitizing antigen for increasing time intervals, then washed and assayed for PCA (Fig. 1) . Cells incubated without antigen showed a very slight increase in PCA at the early time points as compared with PBM assayed immediately after isolation from freshly drawn blood. PBM incubated with sensitizing antigen showed little or no PCA over controls for the first 12 h. Thereafter, there was a steady increase (Fig. 1 ). This makes it unlikely that differences in PCA were due to differences in capabilities of PBM from different donors to express procoagulant. The amount of PCA induced by LPS was generally higher than that induced by antigen. There was not, however, any additive effect on resultant PCA of PBM incubated simultaneously with LPS and antigen (data not shown).
Dose dependence ofPCA response. To determine the threshold level of antigen necessary for initiating the PCA response, increasing concentrations of appropriate antigen were incubated with immune PBM for 48 h. The intact PBM were then assayed for expression of PCA on the cell surface. Fig. 2 was always elicited at 10 gg/ml tularemia antigen. Tularemia immune PBM exposed to increasing concentrations of PPD expressed only base-line levels of PCA. PBM from a PPD-sensitive donor also showed a dose-dependent increase in PCA in response to increasing concentrations ofthat sensitizing antigen, with no PCA expression after exposure to an irrelevant antigen, tularemia. The dose-response curve shown in the lower panel ofFig. 2 is for cells from a single PPDsensitive donor. PBM from all eight PPD-sensitive donors tested showed positive dose-response curves, but the maximum PCA was elaborated at different concentrations ofPPD for each donor.
Cellular source of antigen-induced PCA. To determine the cellular source of PCA expressed by PBM after antigen stimulation, PBM from an individual sensitized to tularemia were incubated 48 h with or without antigen. PBM assayed directly demonstrated the expected fivefold increase in PCA of antigen stimulated vs. control cells. Parallel cultures that had been exposed to antigen were separated via differential adherence to plastic into lymphocytes and monocytes. Table II clearly shows almost all basal PCA to be derived from monocytes, and all incremental PCA in response to antigen to segregate with the monocyte population. In no experiment were lymphocytes seen to increase their PCA above the very low basal levels. Identical experiments with cells from PPD-sensitive donors, and PPD as antigen likewise showed monocytes to be the source of PCA (data not shown).
Cellular interactions in the antigen-specific PCA response. Since monocytes derived from either control or antigen-pulsed PBM were shown to express the vast majority of PCA of the PBM, we tested whether monocytes alone could manifest the PCA response. Monocytes were first isolated from tularemia or PPD-sensitive donors, exposed to sensitizing antigen in vitro, and the resultant PCA monitored (Table III , data from Tularemia-sensitive donors shown). After a 48-h incubation, monocytes exposed to antigen showed no more PCA than monocytes exposed to medium alone. However, monocytes incubated in the presence of lymphocytes and antigen showed a 5-6-fold increment in PCA over monocytes and lymphocytes without antigen (Table II) . Thus, it seemed that monocytes required lymphocytes to manifest an increase in PCA in response to sensitizing antigen. We next determined whether the interaction was lymphocyte to monocyte, as in other PCA responses (17, 18) , or monocyte to lymphocyte to monocyte, as in other antigen driven, non-PCA processes (24) . Lymphocytes pulsed with antigen and washed free of nonbound protein were unable to induce PCA in autologous monocytes to which they were added (Table III) . However, lymphocytes in the presence of autologous adherent monocytes (20:1 ratio) pulsed for 24 h with antigen, washed free of unbound protein, and removed from esterase-positive cells, were able to induce a fresh population ofautologous monocytes to express a sevenfold increase in PCA (Table III) . These data implied antigen presentation by monocytes to lymphocytes. To confirm this, monocytes from a PPD-sensitive individual were allowed to adhere to plastic and the lymphocytes vigorously washed away. The monocytes were incubated 24 h with or without 20 ,ug/ml PPD, washed, and autologous lymphocytes that had been depleted ofmonocytes were added. After another 24 h, the lymphocytes were removed, washed, and added for 24 h to responding monocytes which, after 24 h, were then assayed for PCA. (Table VI) .
Coagulationfactor requirements ofantigen-induced PCA. The PCA assay was repeated on control cultures of PBM, cultures that had been incubated with sensitizing antigen, or with LPS. However, plasmas from individuals congenitally deficient in a single coagulation factor were substituted for normal plasma to determine which factors were necessary for the induced PCA to have its full effect. As shown in Table VII , antigen-induced PCA required the presence ofFactors VII and X, whereas full activity was retained in the absence of Factor VIII. This is the same activity profile demonstrated by LPS-induced PCA.
Discussion
The deposition of fibrin is a prominent feature of lesions of delayed type hypersensitivity, a prototype of cell-mediated immunity. Edwards and Rickles (14) , and Geczy and Meyer (26), have presented compelling evidence that this fibrin deposition is the culmination ofa series of reactions initiated by the expression of procoagulant molecules on the surface of monocytes. The cellular events necessary to express procoagulant molecules on the surface of monocytes and macrophages can be initiated by a variety of stimuli (10) (11) (12) (13) (14) (15) . Among the more extensively studied of these are bacterial LPS (10, 1 1, 17, 19, 27) and antigenantibody complexes (12, 18, 28) . These stimuli are often used to elicit the Shwartzmann reaction in experimental animals, and have been found to initiate unidirectional communication from lymphocytes to monocytes, which then express PCA (17, 18) . The thrombohemorrhagic disorder ofthe Shwartzmann reaction may be due to monocyte PCA. A different set ofcell interactions may be involved in the allogeneic induction of monocyte PCA as Helin and Edgington (29, 30) have recently shown. Currently available experimental data do not adequately address the mechanism by which monocyte PCA can be elicited as a response to a specific sensitizing antigen with no such expression after exposure to a nonsensitizing antigen. The present study demonstrates that human PBM can express potent PCA on their surface as a result of interactions with lymphocytes that have been presented in a specific manner with antigen to which they have been previously sensitized.
All donors for these experiments were sensitive by testing to either PPD or tularemia, but no one was sensitive to both. The degree of increase ofPCA above base-line levels varied somewhat from donor to donor, but was consistent over time for each donor. Among the eight donors sensitive to PPD that were tested, none demonstrated an increase in PBM PCA on exposure to tularemia. Also, [3HjTdR uptake of these PBM upon exposure to tularemia did not increase above baseline, which is in agreement with previous studies (23, 31) .
Geczy and Meyer (26) demonstrated PBM PCA correlated quite well with skin reactivity as a measure of previous sensitization to an antigen. We did not attempt such correlations, as our goal was to define the cellular interactions required for the elaboration of this activity.
Increases in PBM PCA upon exposure to sensitizing antigen reached a maximum between 36 and 72 h. The kinetics of the response varied from individual to individual, with cells from PPD sensitive donors generally showing increased PCA at earlier times than cells from tularemia-sensitive donors. We did not, however, observe the very early increase with subsequent decrease of PCA in exposed cells to PPD reported by Lyberg et al. (32) . It is possible that that study and the present one used different stimuli, as preparations of PPD are a mix of multiple proteins (33) .
The cellular source of the PCA of antigen-stimulated PBM was the monocyte. Using populations > 98% positive for nonspecific esterase staining, we demonstrated that all the PCA resided in the monocyte population, with a negligible amount of activity in the nonspecific esterase-negative lymphocyte population. This is in agreement with a large number of other studies that have looked at the induction of PBM PCA by a number of stimuli (16-18, 29, 34) .
The cellular interactions required for this specific response to sensitizing antigen are demonstrated in this report. There was an absolute requirement for antigen presentation to lymphocytes. Lymphocytes that were free of monocytes that encountered soluble protein antigen were subsequently unable to induce an increase in PCA in responding monocytes. On the other hand, lymphocytes that were presented with protein antigen by monocytes were able, when separated from those monocytes and washed, to induce significant increases in activity among responding monocytes. These data point to a scenario of monocyte uptake of soluble Other antigen-driven systems have been found to depend on non-DR molecules on cells that are HLA-DR positive (37, 38) . It is therefore interesting that anti-HLA-DR should block the PCA response. The disparity cannot be completely explained at present, but it is worth noting that the previous studies were looking at a different response ([PH]thymidine uptake) to antigen than is the present study (PCA expression). Given cell surface molecules may well have different roles in each system. Since we have not employed antibodies to other cell surface histocompatibility proteins, we cannot say what effect they might have on the PCA system. Current studies are underway to elucidate the step at which anti-HLA-DR antibody inhibits the elaboration of specific antigen-induced PCA. In preliminary experiments with purified populations of monocytes and lymphocytes, we have found the monocyte to be the site ofinhibition ofthe procoagulant response by this monoclonal anti-HLA-DR antibody. The use of [3H]thymidine uptake by immune T cells has shown that the antigen presentation step is interfered with by anti-HLA-DR antisera (36) . We have recently described a PPD reactive human T cell clone that mediates the procoagulant response to PPD presented by autologous monocytes (39) . This should prove invaluable in exploring the question of HLA-DR dependence of the reaction, and in defining the point at which HLA-DR is required.
The PCA demonstrated by monocytes in these studies is consistent with tissue factorlike activity. Previous studies described tissue factorlike activity expressed on monocytes after exposure of PBM to specific antigen as well as many other stimuli (13, 15, 18, 29, 40, 41) . Neither of the antigens used as stimuli in this study demonstrated any PCA of their own. The activity was dependent upon the presence of Factors VII and X, and independent of the presence of Factor VIII. However, serial dilution of the monocyte PCA demonstrated a Factor VIII dependency with more dilute procoagulant, in parallel with the Factor VIII dependency of dilute preparations of brain thromboplastin (data not shown) (42, 43) . What's more, the addition ofconcanavallin A to PCA-positive mononuclear cells effectively inhibited the expression of the procoagulant activity (data not shown). These data are consistent with, however not conclusive for, identity of the PCA as tissue factor. Such definitive proof must await the purification of the apoprotein of human tissue factor and development of appropriate antibodies.
This two step (monocyte-lytnphocyte-monocyte) process contrasts with studies ofthe induction ofhuman peripheral blood mononuclear cell PCA by LPS and immune complexes (17, 18) . Both LPS and antigen/antibody-induced PCA involve an initial interaction of the stimulus with a lymphocyte with no requirement for stimulus presentation by monocytes. This lymphocyte is then triggered and able to interact with monocytes, inducing increased PCA. A second, slower induction of monocyte PCA has been recently described. Allogeneic stimuli induce monocyte PCA via T cell instructive mechanisms that differ from LPS or immune complex driven systems (29, 30). The system described in this report then constitutes a third pathway of monocyte procoagulant induction.
